GARDASIL has recently been replaced by a newer version of the vaccine GARDASIL9. Those who started with the original GARDASIL vaccine should continue with this vaccine as it may not be compatible with the new one.
The new GARDASIL 9 should be administered intramuscularly in the deltoid region of the upper arm or in the higher anterolateral area of the thigh at the following schedule: 0, 2 months, 6 months.
GARDASIL 9 is a vaccine indicated in females 9 through 26 years of age for the prevention of cervical, vulvar, vaginal, and anal cancers caused by human papillomavirus (HPV) Types 16, 18, 31, 33, 45, 52, and 58; precancerous or dysplastic lesions caused by HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58; and genital warts caused by HPV Types 6 and 11.
GARDASIL 9 is indicated in males 9 through 26 years of age for the prevention of anal cancer caused by HPV Types 16, 18, 31, 33, 45, 52, and 58; precancerous or dysplastic lesions caused by HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58; and genital warts caused by HPV Types 6 and 11.
The human papillomavirus (HPV) can cause Cervical Cancer that affects the entrance to the womb which is called the Cervix. The virus is spread from one person to another during sexual activity. There a 13 types of HPV known to cause Cervical Cancer out of the 100 different types, out of those 13 types, just two of them cause over 70% of the cases. These two types are 16 and 18.
The virus causes the cancer through damaging cells in the cervix. Initially the virus gets into the surface cells of the Cervix where it can reside for several years without causing any damage. The virus can then for no apparent reason, unexpectedly start to harm the cells. The reason for the cervical screening is to detect the changes early, if detected early enough they can be treated to prevent the development of cancer. If they are left untreated, the cancer may develop and could lead to severe illness and ultimately death.
It’s vital that women still go for routine cervical screening tests when they are older. This vaccine protects against the two virus types that cause over 70% of cervical cancer. The vaccine does not protect against all of the other cancer-causing types.
Studies are in place to measure the long-term protection. If a booster dose of the vaccine is necessary later in life then the person will be informed about this. Studies suggest that vaccinated people maintain high levels of protection for at least seven years, and it is expected to last many years.
Because vaccinees may develop syncope, sometimes resulting in falling with injury, observation for 15 minutes after administration is recommended.
The most common side effects seen with GARDASIL 9 are:pain, swelling, redness, itching, bruising, bleeding, and a lump where you got the shot Headache Fever Nausea Dizziness Tiredness Diarrhea Abdominal pain Sore throat